Targeting small-cell lung cancer with novel fluorescent analogs of somatostatin
Authors:
- Genady KostenichGKGenady Kostenich
- Nurit LivnahNLNurit Livnah
- Thomas A. BonaseraTBThomas A. Bonasera
- Tamar YechezkelTYTamar Yechezkel
- Yosef SalitraYSYosef Salitra
- Pninit LitmanPLPninit Litman
- Sol KimelSKSol Kimel
- Arie OrensteinAOArie Orenstein
- 1 December 2005
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 50 (3) , 319-328
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Improving the specificity of fluorescence bronchoscopy for the analysis of neoplastic lesions of the bronchial tree by combination with optical spectroscopy: preliminary communicationLung Cancer, 2005
- Targeted radiotherapy for small cell lung cancer using 90Yttrium-DOTATOC, an Yttrium-labelled somatostatin analogue: a pilot trialLung Cancer, 2004
- Small cell lung cancer: state of the art and future perspectivesLung Cancer, 2004
- Multiple suspicious lesions detected by autofluorescence bronchoscopy predict malignant development in the bronchial mucosa in high risk patientsLung Cancer, 2003
- Peptide and antibody imaging in lung cancerSeminars in Nuclear Medicine, 2002
- Fluorescence bronchoscopy for early detection of lung cancerLung Cancer, 2001
- Somatostatin Analogs for Cancer Treatment and Diagnosis: An OverviewChemotherapy, 2001
- Somatostatin, Its Receptors and Analogs, in Lung CancerChemotherapy, 2001
- Ten-year survey of lung cancer treatment and survival in hospitals in the United StatesCancer, 1999
- Long term results of surgery and chemotherapy in small cell lung cancer1European Journal of Cardio-Thoracic Surgery, 1998